May 30, 2023 / 12:30PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q4 FY '23 Earnings Conference Call of Torrent Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Sudhir Menon, CFO of Torrent Pharma Limited. Thank you, and over to you, sir.
Sudhir Menon - Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO
Thank you. Good evening, and welcome to quarter 4 FY '23 earnings call. Quarter 4 continued to witness robust growth in branded generic markets, aided by market share gain, performance of the top brands and new launches. The branded generic market, which now constitutes 70% plus of the total revenue has grown 20% plus.
The scheme of arrangement for amalgamation of Curatio is approved by NCLT. And pursuant to this, the business combination has been recognized with effect from 14th of October 2022, which was the acquisition date or the appointed date. The financials now reflect the effect of amalgamation effective 14th of October 2022.
Q4 2023 Torrent Pharmaceuticals Ltd Earnings Call Transcript
May 30, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers